{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:51:25Z","timestamp":1790779885291,"version":"4.1.0"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft, Germany","doi-asserted-by":"publisher","award":["Ro527\/7-1"],"award-info":[{"award-number":["Ro527\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft, Germany","doi-asserted-by":"publisher","award":["SFB-773-TP B02"],"award-info":[{"award-number":["SFB-773-TP B02"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.semcancer.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T01:44:03Z","timestamp":1437183843000},"page":"180-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"special_numbering":"C","title":["Phosphatidylinositol 3-kinase\/Akt signaling as a key mediator of tumor cell responsiveness to radiation"],"prefix":"10.1016","volume":"35","author":[{"given":"Mahmoud","family":"Toulany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Peter","family":"Rodemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2015.07.003_bib1000","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1005","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1953","article-title":"Integration of EGFR inhibitors with radiochemotherapy","volume":"6","author":"Nyati","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1010","first-page":"2166","article-title":"Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis","volume":"6","author":"Huang","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1015","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2006.07.017","article-title":"Preclinical evaluation of molecular-targeted anticancer agents for radiotherapy","volume":"80","author":"Krause","year":"2006","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1517\/14728222.11.4.463","article-title":"The epidermal growth factor receptor in malignant gliomas: Pathogenesis and therapeutic implications","volume":"11","author":"Nakamura","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrclinonc.2010.97","article-title":"Understanding resistance to EGFR inhibitors-impact on future treatment strategies","volume":"7","author":"Wheeler","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.lungcan.2013.03.020","article-title":"Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer","volume":"81","author":"Traynor","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1040","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/09553000701769970","article-title":"Radiation-induced EGFR-signaling and control of DNA-damage repair","volume":"83","author":"Rodemann","year":"2007","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semradonc.2006.11.005","article-title":"Responses of normal cells to ionizing radiation","volume":"17","author":"Rodemann","year":"2007","journal-title":"Semin. Radiat. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.semcancer.2015.07.003_bib1050","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1055\/s-0038-1626525","article-title":"Membrane receptor signaling and control of DNA repair after exposure to ionizing radiation","volume":"49","author":"Toulany","year":"2010","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4161\/cc.5.7.2605","article-title":"Human tumor mutants in the p110alpha subunit of PI3K","volume":"5","author":"Liu","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1070","doi-asserted-by":"crossref","first-page":"C580","DOI":"10.1152\/ajpcell.00375.2009","article-title":"The Akt isoforms are present at distinct subcellular locations","volume":"298","author":"Santi","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1075","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1074\/jbc.M410344200","article-title":"Full activation of PKB\/Akt in response to insulin or ionizing radiation is mediated through ATM","volume":"280","author":"Viniegra","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1080","doi-asserted-by":"crossref","first-page":"41189","DOI":"10.1074\/jbc.M406731200","article-title":"Identification of a PKB\/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase","volume":"279","author":"Feng","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1085","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.97.7.3207","article-title":"Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B\/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells","volume":"97","author":"Persad","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1090","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1593\/neo.06823","article-title":"Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells","volume":"9","author":"Cengel","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1100","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1038\/sj.onc.1206699","article-title":"The RAS signal transduction pathway and its role in radiation sensitivity","volume":"22","author":"McKenna","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1105","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1158\/1078-0432.CCR-11-1054","article-title":"The novel chemical entity YTR107 inhibits recruitment of nucleophosmin to sites of DNA damage, suppressing repair of DNA double-strand breaks and enhancing radiosensitization","volume":"17","author":"Sekhar","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1110","doi-asserted-by":"crossref","first-page":"21206","DOI":"10.1074\/jbc.M703042200","article-title":"Inhibition of phosphatidylinositol-3-OH kinase\/Akt signaling impairs DNA repair in glioblastoma cells following ionizing radiation","volume":"282","author":"Kao","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1115","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1120","doi-asserted-by":"crossref","first-page":"e38033","DOI":"10.1371\/journal.pone.0038033","article-title":"KRASness and PIK3CAness in patients with advanced colorectal cancer: Outcome after treatment with early-phase trials with targeted pathway inhibitors","volume":"7","author":"Garrido-Laguna","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/1568009611313030002","article-title":"Diverse mechanisms of AKT pathway activation in human malignancy","volume":"13","author":"Cheung","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1130","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000015481","article-title":"Mapping of AKT3, encoding a member of the Akt\/protein kinase B family, to human and rodent chromosomes by fluorescence in situ hybridization","volume":"88","author":"Murthy","year":"2000","journal-title":"Cytogenet. Cell Genet."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1515\/bmc.2010.035","article-title":"The Akt isoforms, their unique functions and potential as anticancer therapeutic targets","volume":"1","author":"Santi","year":"2010","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/BST0350231","article-title":"Physiological roles of PKB\/Akt isoforms in development and disease","volume":"35","author":"Dummler","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1145","doi-asserted-by":"crossref","first-page":"38349","DOI":"10.1074\/jbc.C100462200","article-title":"Akt1\/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice","volume":"276","author":"Cho","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1150","doi-asserted-by":"crossref","first-page":"e24432","DOI":"10.1371\/journal.pone.0024432","article-title":"Akt1 is essential for postnatal mammary gland development, function, and the expression of Btn1a1","volume":"6","author":"LaRocca","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2012.03.018","article-title":"Differential function of Akt1 and Akt2 in human adipocytes","volume":"358","author":"Fischer-Posovszky","year":"2012","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1160","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","article-title":"Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)","volume":"292","author":"Cho","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1165","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1128\/MCB.25.5.1869-1878.2005","article-title":"Role for Akt3\/protein kinase Bgamma in attainment of normal brain size","volume":"25","author":"Easton","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1170","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","article-title":"Activation of AKT kinases in cancer: Implications for therapeutic targeting","volume":"94","author":"Bellacosa","year":"2005","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1180","first-page":"885","article-title":"Local recurrence in head and neck cancer: Relationship to radiation resistance and signal transduction","volume":"8","author":"Gupta","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1185","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/sj.bjc.6603180","article-title":"Increased expression of pAKT is associated with radiation resistance in cervical cancer","volume":"94","author":"Kim","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1190","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1195","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1593\/neo.10688","article-title":"Epidermal growth factor receptor in glioma: Signal transduction, neuropathology, imaging, and radioresistance","volume":"12","author":"Hatanpaa","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1200","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1158\/0008-5472.CAN-08-4853","article-title":"EGFRvIII and DNA double-strand break repair: A molecular mechanism for radioresistance in glioblastoma","volume":"69","author":"Mukherjee","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1205","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1038\/sj.onc.1207602","article-title":"Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase\/AKT pathway and promotes radioresistance in cells of astrocytic origin","volume":"23","author":"Li","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1210","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/1541-7786.MCR-06-0297","article-title":"Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity","volume":"5","author":"Toulany","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1215","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr2845","article-title":"Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation","volume":"13","author":"Toulany","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1220","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1158\/0008-5472.CAN-05-0513","article-title":"Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines","volume":"65","author":"Kim","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1225","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.ijrobp.2011.05.057","article-title":"K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs","volume":"81","author":"Minjgee","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2005.06.024","article-title":"Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway","volume":"76","author":"Toulany","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20040825","article-title":"PTEN function: How normal cells control it and tumour cells lose it","volume":"382","author":"Leslie","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1240","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1236188","article-title":"Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress","volume":"341","author":"Bassi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1242\/jcs.022459","article-title":"The nuclear affairs of PTEN","volume":"121","author":"Planchon","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1250","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2009.25.3641","article-title":"The PI3K pathway as drug target in human cancer","volume":"28","author":"Courtney","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12032-010-9473-8","article-title":"Association of sporadic breast cancer with PTEN\/MMAC1\/TEP1 promoter hypermethylation","volume":"28","author":"Sadeq","year":"2011","journal-title":"Med. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1260","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0002-9440(10)64681-0","article-title":"Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas","volume":"158","author":"Kurose","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1265","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.humpath.2012.08.005","article-title":"Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit\/PTEN, and KRAS\/NRAS\/BRAF in primary resected esophageal adenocarcinomas: Loss of PTEN is associated with worse clinical outcome","volume":"44","author":"Bettstetter","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fcell.2015.00024","article-title":"Nuclear PI3K signaling in cell growth and tumorigenesis","volume":"3","author":"Davis","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1275","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jcb.10287","article-title":"Frequent activation of AKT2 kinase in human pancreatic carcinomas","volume":"87","author":"Altomare","year":"2002","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1280","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/jcp.2004.024786","article-title":"Prognostic value of activated Akt expression in oral squamous cell carcinoma","volume":"58","author":"Lim","year":"2005","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1285","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.humpath.2012.03.015","article-title":"Molecular alterations in AKT and its protein activation in human lung carcinomas","volume":"43","author":"Dobashi","year":"2012","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1290","first-page":"6105","article-title":"Overexpression and overactivation of Akt in thyroid carcinoma","volume":"61","author":"Ringel","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1295","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.84.14.5034","article-title":"Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma","volume":"84","author":"Staal","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2559.2009.03467.x","article-title":"Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH","volume":"56","author":"Kirkegaard","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2009.09.038","article-title":"AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma","volume":"116","author":"Cohen","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1310","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/onc.2009.315","article-title":"AKT1 mutations in bladder cancer: Identification of a novel oncogenic mutation that can co-operate with E17K","volume":"29","author":"Askham","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1315","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/cc.7.5.5485","article-title":"Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung","volume":"7","author":"Malanga","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1320","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1038\/onc.2008.170","article-title":"AKT1(E17K) in human solid tumours","volume":"27","author":"Bleeker","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1325","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0163-7258(02)00193-6","article-title":"Inhibition of protein kinase B\/Akt. implications for cancer therapy","volume":"93","author":"Hill","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1330","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","article-title":"Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1335","doi-asserted-by":"crossref","first-page":"620601","DOI":"10.4061\/2011\/620601","article-title":"Molecular characteristics of pancreatic ductal adenocarcinoma","volume":"2011","author":"Ottenhof","year":"2011","journal-title":"Pathol. Res. Int."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1340","first-page":"25","article-title":"Akt2 expression correlates with prognosis of human hepatocellular carcinoma","volume":"11","author":"Xu","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1345","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4161\/cbt.5.7.2751","article-title":"Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms","volume":"5","author":"Nakayama","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1350","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1038\/sj.onc.1205438","article-title":"AKT2 is frequently upregulated in HER-2\/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival","volume":"21","author":"Bacus","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1355","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.89.19.9267","article-title":"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine\/threonine kinases, is amplified in human ovarian carcinomas","volume":"89","author":"Cheng","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1360","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1365","first-page":"2973","article-title":"AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1370","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000096289","article-title":"Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas","volume":"70","author":"Soung","year":"2006","journal-title":"Oncology"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1375","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1073\/pnas.0901933106","article-title":"Insulin-modulated Akt subcellular localization determines Akt isoform-specific signaling","volume":"106","author":"Gonzalez","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1380","doi-asserted-by":"crossref","first-page":"e92948","DOI":"10.1371\/journal.pone.0092948","article-title":"AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake","volume":"9","author":"Rashmi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1385","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1074\/jbc.M115.660498","article-title":"Signaling through the phosphatidylinositol 3-kinase (PI3K)\/mammalian target of rapamycin (mTOR) axis is responsible for aerobic glycolysis mediated by glucose transporter in epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma","volume":"290","author":"Makinoshima","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1390","doi-asserted-by":"crossref","first-page":"e1160","DOI":"10.1038\/cddis.2014.125","article-title":"Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma","volume":"5","author":"Hudson","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1395","doi-asserted-by":"crossref","first-page":"e14614","DOI":"10.1371\/journal.pone.0014614","article-title":"Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells","volume":"6","author":"Santi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1400","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1158\/0008-5472.CAN-06-1968","article-title":"A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition","volume":"66","author":"Cristiano","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1405","doi-asserted-by":"crossref","first-page":"21528","DOI":"10.1074\/jbc.274.31.21528","article-title":"Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines","volume":"274","author":"Nakatani","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1410","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1073\/pnas.1414573112","article-title":"Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression","volume":"112","author":"Turner","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1415","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1158\/0008-5472.CAN-04-1399","article-title":"Deregulated Akt3 activity promotes development of malignant melanoma","volume":"64","author":"Stahl","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1420","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjc.6604637","article-title":"A novel AKT3 mutation in melanoma tumours and cell lines","volume":"99","author":"Davies","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1425","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1432-1327.1999.00774.x","article-title":"Molecular cloning, expression and characterization of the human serine\/threonine kinase Akt-3","volume":"265","author":"Masure","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1430","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1158\/0008-5472.CAN-06-4234","article-title":"PRAS40 deregulates apoptosis in malignant melanoma","volume":"67","author":"Madhunapantula","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1435","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/BJ20150041","article-title":"Akt\/PKB: One kinase, many modifications","volume":"468","author":"Risso","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1440","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2045-3701-4-59","article-title":"Posttranslational regulation of Akt in human cancer","volume":"4","author":"Chan","year":"2014","journal-title":"Cell Biosci."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1445","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/35077225","article-title":"Oncogenic kinase signalling","volume":"411","author":"Blume-Jensen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1450","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1038\/sj.onc.1209737","article-title":"Cisplatin induces PKB\/Akt activation and p38(MAPK) phosphorylation of the EGF receptor","volume":"25","author":"Winograd-Katz","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2011.06.022","article-title":"Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma","volume":"101","author":"Nijkamp","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1460","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1158\/1940-6207.CAPR-08-0080","article-title":"Deregulated EGFR signaling during lung cancer progression: Mutations, amplicons, and autocrine loops","volume":"1","author":"Gazdar","year":"2008","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1465","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1371\/journal.pmed.0020377","article-title":"Inhibition of EGFR signaling: All mutations are not created equal","volume":"2","author":"Gazdar","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1470","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2011.02.043","article-title":"Cellular and tumor radiosensitivity is correlated to epidermal growth factor receptor protein expression level in tumors without EGFR amplification","volume":"80","author":"Kasten-Pisula","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1475","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1520-6823(1997)5:4<180::AID-ROI3>3.0.CO;2-U","article-title":"Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck","volume":"5","author":"Sheridan","year":"1997","journal-title":"Radiat. Oncol. Investig."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1480","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2011.06.001","article-title":"Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access","volume":"99","author":"Dittmann","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1485","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.radonc.2012.03.008","article-title":"EGFR-mediated stimulation of sodium\/glucose cotransport promotes survival of irradiated human A549 lung adenocarcinoma cells","volume":"103","author":"Huber","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1490","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2004.11.008","article-title":"Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS","volume":"74","author":"Toulany","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1495","first-page":"1683","article-title":"Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation","volume":"24","author":"Zhang","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1500","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1158\/1535-7163.MCT-06-0596","article-title":"Radiation-induced cell signaling: Inside-out and outside-in","volume":"6","author":"Valerie","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1505","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.radonc.2010.03.008","article-title":"ErbB2 expression through heterodimerization with erbB1 is necessary for ionizing radiation- but not EGF-induced activation of Akt survival pathway","volume":"97","author":"Toulany","year":"2010","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1748-717X-4-43","article-title":"Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells","volume":"4","author":"Li","year":"2009","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1515","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S1470-2045(08)70073-1","article-title":"Activation of the PI3-K\/AKT pathway and implications for radioresistance mechanisms in head and neck cancer","volume":"9","author":"Bussink","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1520","first-page":"915","article-title":"Phosphatidylinositide 3-kinase\/AKT in radiation responses","volume":"19","author":"Zhan","year":"2004","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1525","first-page":"246","article-title":"The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage","volume":"56","author":"Price","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1530","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IGC.0b013e3182021bfd","article-title":"Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo","volume":"21","author":"Liu","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1535","first-page":"3986","article-title":"Akt\/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation","volume":"61","author":"Brognard","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1540","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1158\/0008-5472.CAN-08-0757","article-title":"Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity","volume":"68","author":"Prevo","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1545","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ygyno.2007.08.073","article-title":"Radiosensitization of cervical cancer cells via double-strand DNA break repair inhibition","volume":"110","author":"Fuhrman","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1550","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1158\/1541-7786.MCR-09-0507","article-title":"Targeting epidermal growth factor receptor-associated signaling pathways in non-small cell lung cancer cells: Implication in radiation response","volume":"8","author":"Choi","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1555","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-05-1084","article-title":"Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines","volume":"12","author":"Lee","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1560","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1158\/0008-5472.CAN-03-1788","article-title":"Serine\/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance","volume":"64","author":"Tanno","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1565","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1073\/pnas.0914242107","article-title":"Nuclear phosphoinositide 3-kinase beta controls double-strand break DNA repair","volume":"107","author":"Kumar","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1570","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jcb.25091","article-title":"The upregulation of PI3K\/Akt and MAP kinase pathways is associated with resistance of microtubule-targeting drugs in prostate cancer","volume":"116","author":"Liu","year":"2015","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1575","first-page":"5303","article-title":"Prevention of phosphatidylinositol 3\u2032-kinase-Akt survival signaling pathway during topotecan-induced apoptosis","volume":"60","author":"Nakashio","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1580","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00210-014-1032-y","article-title":"The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells","volume":"388","author":"Lin","year":"2015","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1585","doi-asserted-by":"crossref","first-page":"e93996","DOI":"10.1371\/journal.pone.0093996","article-title":"Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcoma","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-7-1","article-title":"Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin\/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors","volume":"7","author":"Molife","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1595","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00280-015-2693-z","article-title":"Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors","volume":"75","author":"Hyman","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1600","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00066-014-0620-6","article-title":"Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer","volume":"190","author":"Lazaridis","year":"2014","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1605","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-012-2376-y","article-title":"Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit","volume":"137","author":"Bostner","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1610","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0092-8674(00)80405-5","article-title":"Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery","volume":"91","author":"Datta","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1615","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1038\/sj.onc.1205664","article-title":"Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1\/Akt signaling in human multiple myeloma cells: Therapeutic implications","volume":"21","author":"Mitsiades","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1620","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/sj.leu.2403044","article-title":"A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells","volume":"17","author":"Martelli","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1625","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1074\/jbc.M512000200","article-title":"Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells","volume":"281","author":"Choi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1630","doi-asserted-by":"crossref","first-page":"21085","DOI":"10.1074\/jbc.M400063200","article-title":"Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils","volume":"279","author":"Gardai","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1635","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1158\/1535-7163.MCT-07-2200","article-title":"Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair","volume":"7","author":"Toulany","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1640","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1101\/gad.1627008","article-title":"PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo","volume":"22","author":"Hambardzumyan","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1645","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.oraloncology.2014.11.005","article-title":"AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines","volume":"51","author":"Ettl","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1650","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.18632\/oncotarget.3332","article-title":"Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1655","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.18632\/oncotarget.2975","article-title":"NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1660","doi-asserted-by":"crossref","first-page":"e1437","DOI":"10.1038\/cddis.2014.415","article-title":"PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways","volume":"5","author":"Chang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1665","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3892\/ijo.2014.2614","article-title":"Radiation-induced signaling pathways that promote cancer cell survival (review)","volume":"45","author":"Hein","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1670","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1675","doi-asserted-by":"crossref","first-page":"e875","DOI":"10.1038\/cddis.2013.407","article-title":"Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K\/Akt\/mTOR pathway in prostate cancer radioresistance","volume":"4","author":"Chang","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1680","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13402-011-0020-1","article-title":"Pharmacological inhibition of AKT sensitizes MCF-7 human breast cancer-initiating cells to radiation","volume":"34","author":"Zhan","year":"2011","journal-title":"Cell Oncol. (Dordr.)"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1685","doi-asserted-by":"crossref","first-page":"e94621","DOI":"10.1371\/journal.pone.0094621","article-title":"Evaluation of cancer stem cell markers CD133, CD44, CD24: Association with AKT isoforms and radiation resistance in colon cancer cells","volume":"9","author":"Sahlberg","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1690","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.radonc.2013.10.040","article-title":"CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells","volume":"110","author":"Desai","year":"2014","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1695","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2011.10.012","article-title":"CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma","volume":"315","author":"Piao","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1700","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1073\/pnas.0910179107","article-title":"Selective targeting of radiation-resistant tumor-initiating cells","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1705","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2012.08.030","article-title":"Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells","volume":"48","author":"Lin","year":"2012","journal-title":"Mol. Cell."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1710","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1476-4598-11-73","article-title":"EGFR\/Src\/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer","volume":"11","author":"Singh","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1715","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1158\/1535-7163.MCT-14-0708","article-title":"Radiosensitization of primary human glioblastoma stem-like cells with low-dose AKT inhibition","volume":"14","author":"Mehta","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1720","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2011.06.003","article-title":"Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro","volume":"99","author":"Mihatsch","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1725","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ijrobp.2011.11.037","article-title":"Gefitinib radiosensitizes stem-like glioma cells: Inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair","volume":"83","author":"Kang","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1730","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1158\/0008-5472.CAN-07-0562","article-title":"Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy","volume":"68","author":"Apel","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1735","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI40027","article-title":"The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5","volume":"120","author":"Rouschop","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1740","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.radonc.2011.06.002","article-title":"Autophagy contributes to resistance of tumor cells to ionizing radiation","volume":"99","author":"Chaachouay","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1745","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-144-5-200603070-00008","article-title":"Adding chloroquine to conventional treatment for glioblastoma multiforme: A randomized, double-blind, placebo-controlled trial","volume":"144","author":"Sotelo","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1750","doi-asserted-by":"crossref","first-page":"293","DOI":"10.18632\/genesandcancer.27","article-title":"NVP-BEZ-235 enhances radiosensitization via blockade of the PI3K\/mTOR pathway in cisplatin-resistant non-small cell lung carcinoma","volume":"5","author":"Kim","year":"2014","journal-title":"Genes Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1755","first-page":"753","article-title":"Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy","volume":"31","author":"Fujiwara","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1760","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14728214.2015.1031217","article-title":"Update on emerging treatments for chronic myeloid leukemia","volume":"20","author":"Fava","year":"2015","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1765","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2217\/fon.15.57","article-title":"A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas","volume":"11","author":"Feugier","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1770","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1158\/0008-5472.CAN-05-0422","article-title":"Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation","volume":"65","author":"Brandts","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1775","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/pbc.25151","article-title":"Frequent coexistence of RAS mutations in RUNX1-mutated acute myeloid leukemia in Arab Asian children","volume":"61","author":"Al-Kzayer","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1780","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000227023","article-title":"Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia","volume":"49","author":"Nakagawa","year":"1992","journal-title":"Oncology"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1785","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2013-02-484386","article-title":"Insulin-like growth factor-1 receptor (IGF1R) as a novel target in chronic lymphocytic leukemia","volume":"122","author":"Yaktapour","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1790","first-page":"976567","article-title":"Molecularly targeted therapies in multiple myeloma","volume":"2014","author":"de la Puente","year":"2014","journal-title":"Leuk. Res. Treat."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1795","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00018-015-1867-5","article-title":"Targeting PI3K\/AKT\/mTOR network for treatment of leukemia","volume":"72","author":"Bertacchini","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1800","first-page":"299","article-title":"Targeting the PI3K\/AKT\/mTOR signaling axis in children with hematologic malignancies","volume":"14","author":"Barrett","year":"2012","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1805","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.2174\/0929867321666140601204513","article-title":"Targeting the phosphatidylinositol 3-kinase\/AKT pathway for the treatment of multiple myeloma","volume":"21","author":"Zhu","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1810","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1158\/1078-0432.CCR-05-2454","article-title":"Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair","volume":"12","author":"Toulany","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1815","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2012.08.010","article-title":"Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways","volume":"105","author":"Raju","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1820","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2011.05.046","article-title":"In tumor cells regulation of DNA double strand break repair through EGF receptor involves both NHEJ and HR and is independent of p53 and K-Ras status","volume":"101","author":"Myllynen","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1825","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1158\/1541-7786.MCR-11-0592","article-title":"Akt1 promotes post-irradiation survival of human tumor cells through initiation, progression and termination of DNA-PKcs-dependent DNA-double strand break repair","volume":"10","author":"Toulany","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1830","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.4161\/cc.10.13.16305","article-title":"MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks","volume":"10","author":"Fraser","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1835","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/85798","article-title":"DNA double-strand breaks: Signaling, repair and the cancer connection","volume":"27","author":"Khanna","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1840","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000077461","article-title":"Mechanisms of DNA double strand break repair and chromosome aberration formation","volume":"104","author":"Iliakis","year":"2004","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1845","first-page":"22","article-title":"Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment","volume":"1","author":"Hsu","year":"2012","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1850","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ijrobp.2012.02.014","article-title":"Fromont G. DNA-PKcs expression predicts response to radiotherapy in prostate cancer","volume":"84","author":"Bouchaert","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1855","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1093\/nar\/gkm339","article-title":"Phosphorylation in the serine\/threonine 2609\u20132647 cluster promotes but is not essential for DNA-dependent protein kinase-mediated nonhomologous end joining in human whole-cell extracts","volume":"35","author":"Povirk","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1860","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj20020973","article-title":"Identification of in vitro and in vivo phosphorylation sites in the catalytic subunit of the DNA-dependent protein kinase","volume":"368","author":"Douglas","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1865","doi-asserted-by":"crossref","first-page":"14709","DOI":"10.1074\/jbc.M408827200","article-title":"Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1870","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1074\/jbc.M611605200","article-title":"Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break","volume":"282","author":"Chen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1875","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1074\/jbc.C800210200","article-title":"DNA-dependent protein kinase-mediated phosphorylation of protein kinase B requires a specific recognition sequence in the C-terminal hydrophobic motif","volume":"284","author":"Park","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1880","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molcel.2008.02.024","article-title":"PKBalpha\/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival","volume":"30","author":"Bozulic","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1885","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2011.06.004","article-title":"Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation","volume":"101","author":"Toulany","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1890","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.semradonc.2010.05.002","article-title":"Targeting nonhomologous end-joining through epidermal growth factor receptor inhibition: Rationale and strategies for radiosensitization","volume":"20","author":"Mukherjee","year":"2010","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1895","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4161\/cc.8.15.9222","article-title":"Linking PTEN with genomic instability and DNA repair","volume":"8","author":"Meyn","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1900","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hed.22954","article-title":"Increased radioresistance via G12S K-Ras by compensatory upregulation of MAPK and PI3K pathways in epithelial cancer","volume":"35","author":"Affolter","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1905","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1038\/sj.onc.1210880","article-title":"ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks","volume":"26","author":"Lavin","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1910","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.radonc.2011.06.019","article-title":"The role of homologous recombination in radiation-induced double-strand break repair","volume":"101","author":"Jeggo","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1915","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.dnarep.2010.09.013","article-title":"The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax","volume":"9","author":"Goodarzi","year":"2010","journal-title":"DNA Repair"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1920","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/emboj.2009.276","article-title":"ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2","volume":"28","author":"Beucher","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1925","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1074\/jbc.M410344200","article-title":"Full activation of PKB\/Akt in response to insulin or ionizing radiation is mediated through ATM","volume":"280","author":"Viniegra","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1930","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4161\/cc.10.3.14713","article-title":"ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks","volume":"10","author":"Khalil","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1935","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2011.05.074","article-title":"DNA double-strand break \u2013 Induced pro-survival signaling","volume":"101","author":"Hawkins","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1940","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1945","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1200\/JCO.2001.19.8.2247","article-title":"Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic","volume":"19","author":"Martin","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1950","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1038\/onc.2010.603","article-title":"Targeting the Akt\/mTOR pathway in Brca1-deficient cancers","volume":"30","author":"Xiang","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1955","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1158\/0008-5472.CAN-08-0861","article-title":"AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51","volume":"68","author":"Plo","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1960","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/onc.2012.211","article-title":"Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway","volume":"32","author":"Jia","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1965","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4161\/cc.4.7.1795","article-title":"PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells","volume":"4","author":"Puc","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1970","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4161\/cc.26465","article-title":"Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation","volume":"12","author":"Choi","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1975","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1158\/0008-5472.CAN-08-1127","article-title":"Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells","volume":"68","author":"Li","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1980","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00109-011-0844-1","article-title":"The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms","volume":"90","author":"Ciuffreda","year":"2012","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.semcancer.2015.07.003_bib1985","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4161\/cbt.27311","article-title":"ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition","volume":"15","author":"Toulany","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1990","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1158\/0008-5472.CAN-08-4765","article-title":"PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers","volume":"69","author":"Wee","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2015.07.003_bib1995","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1200\/JCO.2010.33.9788","article-title":"Perifosine plus bortezomib and dexamethasone in patients with relapsed\/refractory multiple myeloma previously treated with bortezomib: Results of a multicenter phase I\/II trial","volume":"29","author":"Richardson","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2000","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00280-014-2569-7","article-title":"A phase I and pharmacokinetic study of oral perifosine with different loading schedules in patients with refractory neoplasms","volume":"74","author":"Figg","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11060-013-1303-3","article-title":"A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme","volume":"116","author":"Alonso-Basanta","year":"2014","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2010","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.radonc.2013.03.023","article-title":"Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer","volume":"107","author":"Buijsen","year":"2013","journal-title":"Radiother. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2015.07.003_bib2015","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju493","article-title":"SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer","volume":"107","author":"Gonzalez-Angulo","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2020","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/bjc.2014.497","article-title":"A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours","volume":"111","author":"Brana","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2015.07.003_bib2025","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2014-03-559963","article-title":"The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma","volume":"124","author":"Spencer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2015.07.003_bib2030","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2174\/138161213804547286","article-title":"Targeting the Akt-pathway to improve radiosensitivity in glioblastoma","volume":"19","author":"Narayan","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: An updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR Signaling in Cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2045","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/aps.2012.72","article-title":"PI3K and Akt as molecular targets for cancer therapy: Current clinical outcomes","volume":"33","author":"Pal","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.radonc.2006.07.032","article-title":"Phase I and pharmacokinetic study of combined treatment with perifosine and radiation in patients with advanced solid tumours","volume":"80","author":"Vink","year":"2006","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2055","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/JTO.0b013e3182435aa6","article-title":"A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA\/IIIB non-small cell lung cancer: A report of toxicities and clinical response","volume":"7","author":"Rengan","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.semcancer.2015.07.003_bib2060","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1200\/JCO.2007.15.2355","article-title":"Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer","volume":"26","author":"Brunner","year":"2008","journal-title":"J. Clin. Oncol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X15000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X15000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T01:53:54Z","timestamp":1599270834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X15000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":213,"alternative-id":["S1044579X15000620"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2015.07.003","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphatidylinositol 3-kinase\/Akt signaling as a key mediator of tumor cell responsiveness to radiation","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}